Page last updated: 2024-10-19

orotic acid and Arteriosclerosis

orotic acid has been researched along with Arteriosclerosis in 9 studies

Orotic Acid: An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.
orotic acid : A pyrimidinemonocarboxylic acid that is uracil bearing a carboxy substituent at position C-6.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19907 (77.78)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jellinek, H2
Takács, E2
Schmidt-Gayk, H1
Rühland, W1
Wernecke, O1
Gorbachev, VV2
Vecherskiĭ, GA2
Baranov, LG2
Nieper, HA1
Villányi, P1
Votin, J1
Rahlfs, V1
Simon, KH1

Trials

1 trial available for orotic acid and Arteriosclerosis

ArticleYear
[Testing of the clinical effects of a cavain-magnesium-orotate combination in inmates of a nursing home using a double-blind study].
    Zeitschrift fur Alternsforschung, 1975, Volume: 29, Issue:3

    Topics: Age Factors; Aged; Arteriosclerosis; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; F

1975

Other Studies

8 other studies available for orotic acid and Arteriosclerosis

ArticleYear
[Morphological aspects of the effect of magnesium orotate therapy on changes in the vascular walls induced by cholesterol-rich diet].
    Orvosi hetilap, 1997, Sep-07, Volume: 138, Issue:36 Suppl 2

    Topics: Animals; Arteriosclerosis; Cholesterol, Dietary; Diet, Atherogenic; Disease Models, Animal; Hypercho

1997
[Course of the progression of experimentally induced arteriosclerotic vessel wall changes after treatment with magnesium orotate] .
    Arzneimittel-Forschung, 2000, Volume: 50, Issue:12

    Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Blood Vessels; Cholesterol; Cholesterol, HDL; C

2000
[Letter: Prevention of arteriosclerosis and calcium deficiency symptoms?].
    Medizinische Klinik, 1976, Sep-10, Volume: 71, Issue:37

    Topics: Arteriosclerosis; Calcium; Humans; Hypocalcemia; Orotic Acid

1976
[Effect of potassium orotate on the indicators of rheohepatogram in patients with coronary arteriosclerosis].
    Terapevticheskii arkhiv, 1975, Volume: 47, Issue:1

    Topics: Adult; Aged; Arteriosclerosis; Coronary Disease; Female; Follow-Up Studies; Hemodynamics; Hepatic Ar

1975
[Effect of potassium orotate on the contractile function of the myocardium in patients with coronary aterosclerosis].
    Klinicheskaia meditsina, 1975, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Aged; Arteriosclerosis; Coronary Disease; Heart; Heart Function Tests; Humans; Mi

1975
Capillarographic criteria on the effect of magnesium orotate, EPL substances and clofibrate on the elasticity of blood vessels.
    Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1974, Volume: 15, Issue:1

    Topics: Arteriosclerosis; Capillaries; Capillary Fragility; Clofibrate; Elasticity; Humans; Magnesium; Oroti

1974
[Arteriosclerosis, myocardial infarct and blood lipids, their therapeutic modification by magnesium orotate].
    Wiener medizinische Wochenschrift (1946), 1970, Jan-31, Volume: 120, Issue:5

    Topics: Age Factors; Aged; Aorta; Arteriosclerosis; Cholesterol; Depression, Chemical; Humans; Lipids; Magne

1970
[Causes of the multilayered effect of magnesium orotate in degenerative heart and vascular diseases (vascular sclerosis)].
    Deutsches medizinisches Journal, 1968, Dec-20, Volume: 19, Issue:24

    Topics: Arteriosclerosis; Coronary Disease; Humans; Magnesium; Magnesium Deficiency; Orotic Acid

1968